Subsidy Information and Financing Scheme

Not Applicable

Drug Guidance for Subsidy

01/09/2020 Benralizumab, mepolizumab and omalizumab for treating severe asthma

NR

The Ministry of Health’s Drug Advisory Committee has not recommended listing:

  • Benralizumab ...
General Availability in Public Healthcare Institution
Users are to consult the respective PHIs for actual inventory availability and supply restrictions/consideration

List of monographs containing this active ingredient

Benralizumab [Fasenra]